4-(2-FLUOROPHENOXY)-3-METHYLANILINE
- $110 - $802.73
- Product name: 4-(2-FLUOROPHENOXY)-3-METHYLANILINE
- CAS: 946698-56-2
- MF: C13H12FNO
- MW: 217.24
- EINECS:
- MDL Number:MFCD08687893
- Synonyms:4-(2-FLUOROPHENOXY)-3-METHYLANILINE;Benzenamine, 4-(2-fluorophenoxy)-3-methyl-
5 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
- TRC
Package
- 50mg
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number4038AF
- Product description4-(2-Fluorophenoxy)-3-methylaniline
- Packaging500mg
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0033444
- Product description4-(2-FLUOROPHENOXY)-3-METHYLANILINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12003492
- Product description4-(2-Fluorophenoxy)-3-methylaniline 97%
- Packaging5g
- Price$648
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022667
- Product description4-(2-Fluorophenoxy)-3-methylaniline
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberF792025
- Product description4-(2-Fluorophenoxy)-3-methylaniline
- Packaging50mg
- Price$110
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4038AF | 4-(2-Fluorophenoxy)-3-methylaniline | 500mg | $326 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0033444 | 4-(2-FLUOROPHENOXY)-3-METHYLANILINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
Crysdot | CD12003492 | 4-(2-Fluorophenoxy)-3-methylaniline 97% | 5g | $648 | 2021-12-16 | Buy |
Matrix Scientific | 022667 | 4-(2-Fluorophenoxy)-3-methylaniline | 500mg | $205 | 2021-12-16 | Buy |
TRC | F792025 | 4-(2-Fluorophenoxy)-3-methylaniline | 50mg | $110 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|